Evidence map›Paper›PMID 29043954›Full record

ArticleMicrobiology (Reading, England)2017

N-acetylglucosamine affects Cryptococcus neoformans cell-wall composition and melanin architecture.

Emma Camacho, Christine Chrissian, Radames J B Cordero, Livia Liporagi-Lopes, Ruth E Stark, Arturo Casadevall

Abstract read
In one paragraph

Article in Microbiology (Reading, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Melanization ofJournal of fungi (Basel, Switzerland) · 2022
    Article
  7. Article
  8. Pyomelanin Synthesis inFrontiers in microbiology · 2021
    Article
  9. Article
  10. Article
  11. N-Acetylglucosamine (GlcNAc) Sensing, Utilization, and Functions inJournal of fungi (Basel, Switzerland) · 2020
    Review
  12. Melanin deposition in twoThe Journal of biological chemistry · 2020
    Article
  13. Article
  14. Journal of fungi (Basel, Switzerland) · 2019
    Review
  15. Article
  16. Article
  17. Molecular Mechanisms of Chitosan Interactions with Fungi and Plants.International journal of molecular sciences · 2019
    Review
  18. The Fungal Cell Wall:Frontiers in microbiology · 2019
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Emma CamachoDepartment of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
Christine ChrissianPhD Program in Biochemistry, The Graduate Center of the City University of New York, New York, NY, USA.
Radames J B CorderoDepartment of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
Livia Liporagi-LopesFaculdade de Farmácia, Centro de Ciências da Saúde, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Ruth E StarkPhD Program in Biochemistry, The Graduate Center of the City University of New York, New York, NY, USA.
Arturo CasadevallDepartment of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
Johns Hopkins University · USCity University of New York · USUniversidade Federal do Rio de Janeiro · BR

Funding

Cellular/Molecular Basis of Development: Research CenterG12MD007603 · NIMHD · CITY COLLEGE OF NEW YORK · PI PEZZANO, MARK · 2012 to 2017
$11.5M
Biology of Fungal MelaninR01AI052733 · NIAID · YESHIVA UNIVERSITY · PI CASADEVALL, ARTURO · 2003 to 2019
$6.6M
NIAID NIH HHS R01 AI052733NIMHD NIH HHS G12 MD007603
6 · The paper itself

Abstract

Cryptococcus neoformans is an environmental fungus that belongs to the phylum Basidiomycetes and is a major pathogen in immunocompromised patients. The ability of C. neoformans to produce melanin pigments represents its second most important virulence factor, after the presence of a polysaccharide capsule. Both the capsule and melanin are closely associated with the fungal cell wall, a complex structure that is essential for maintaining cell morphology and viability under conditions of stress. The amino sugar N-acetylglucosamine (GlcNAc) is a key constituent of the cell-wall chitin and is used for both N-linked glycosylation and GPI anchor synthesis. Recent studies have suggested additional roles for GlcNAc as an activator and mediator of cellular signalling in fungal and plant cells. Furthermore, chitin and chitosan polysaccharides interact with melanin pigments in the cell wall and have been found to be essential for melanization. Despite the importance of melanin, its molecular structure remains unresolved; however, we previously obtained critical insights using advanced nuclear magnetic resonance (NMR) and imaging techniques. In this study, we investigated the effect of GlcNAc supplementation on cryptococcal cell-wall composition and melanization. C. neoformans was able to metabolize GlcNAc as a sole source of carbon and nitrogen, indicating a capacity to use a component of a highly abundant polymer in the biospherenutritionally. C. neoformans cells grown with GlcNAc manifested changes in the chitosan cell-wall content, cell-wall thickness and capsule size. Supplementing cultures with isotopically

Indexed as

AcetylglucosamineCell WallChitinChitosanCryptococcus neoformansDrug Resistance, FungalEnzyme AssaysLaccaseMelaninsMicrobial Sensitivity TestsPhenotypeAcetylglucosamineChitinChitosanLaccaseMelaninschitinchitosanfungal cell wallmelaninN-acetylglucosamine

Identifiers

PMID29043954
PMCPMC5775898
OpenAlexW2766909603

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.